Alimera Sciences, Inc.;The Johns Hopkins University
发明人:
Kenneth E. Green,Peter Campochiaro,Yogita Kanan
申请号：
US16401385
公开号：
US20190336466A1
申请日:
2019.05.02
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A method of treating or inhibiting degeneration of a retina of a subject in need thereof comprising administering an effective amount of a compound of metipranolol, or a metabolite thereof, to an organ, a tissue, or the subject, wherein the degeneration of the retina is caused by an ocular disease. In some embodiments, the compound, or a metabolite thereof, is administered topically, orally, or parenterally. In some embodiments, a drug delivery vehicle comprising a dosage of the compound, or the metabolite of, is delivered parenterally via intravitreal injection. In further embodiments, the dosage may range from 0.5 μg/day-15 μg/day.
